Hikal informs about inform press release

05 May 2021 Evaluate

Hikal has informed that it has enclosed a copy of the press release on 5th May 2021, titled ‘Hikal signs a 10-year multi product deal with a leading global pharmaceutical innovator company’ regarding long term contract entered into by the Company with a leading global pharmaceutical innovator company. Treat this as an intimation under Regulation 30 of SEBI LODR.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.